The company's fundamentals are relatively stable. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite a very weak stock market performance, the company shows strong technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Cigna Group's Score
Industry at a Glance
Industry Ranking
32 / 78
Overall Ranking
147 / 4621
Industry
Healthcare Providers & Services
Support & Resistance
No Data
Score Analysis
Current score
Previous score
Analyst Rating
Based on
27
analysts
Buy
Current Rating
360.212
Target Price
+20.42%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Cigna Group Highlights
StrengthsRisks
The Cigna Group is a global health company. The Company has two growth platforms: Evernorth Health Services and Cigna Healthcare. The Company’s portfolio of offerings solves diverse challenges across the healthcare system. Evernorth Health Services includes a range of independent and coordinated health solutions and capabilities designed to enable the healthcare system to help people live richer, healthier lives. Health plans, employers, governmental organizations and health care providers partner with Evernorth Health Services to solve their challenges in the areas of pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty distribution, and care delivery and management solutions. Cigna Healthcare includes the United States healthcare and international health businesses, which provide comprehensive medical and coordinated solutions to clients and customers. Its Other Operations include corporate-owned life insurance (COLI) and the Company's run-off operations.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 36.90% year-on-year.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 45.63%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 45.63%.
Undervalued
The company’s latest PE is 13.43, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 240.06M shares, decreasing 4.06% quarter-over-quarter.
The Cigna Group is a global health company. The Company has two growth platforms: Evernorth Health Services and Cigna Healthcare. The Company’s portfolio of offerings solves diverse challenges across the healthcare system. Evernorth Health Services includes a range of independent and coordinated health solutions and capabilities designed to enable the healthcare system to help people live richer, healthier lives. Health plans, employers, governmental organizations and health care providers partner with Evernorth Health Services to solve their challenges in the areas of pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty distribution, and care delivery and management solutions. Cigna Healthcare includes the United States healthcare and international health businesses, which provide comprehensive medical and coordinated solutions to clients and customers. Its Other Operations include corporate-owned life insurance (COLI) and the Company's run-off operations.